TherapeuticsMD, Inc. (TXMD) stock
Close on Nov 11, 2026Market cap $21.41MP/E –Yield –
TherapeuticsMD, Inc. grew revenue 27.8% to $3.27M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $21.41M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $21.41M
- P/E ratio
- –
- Price to sales
- 6.55
- Price to book
- 0.79
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.27M
- Net income
- -$217.00K
- EPS, diluted
- -$0.02
- Book value per share
- $2.33
- Diluted shares
- 12M
Trading
- Next earnings
- Nov 12, 2026 (estimated, during market hours)
- Previous close
- $1.74
- Open
- $1.74
- Day's range
- $1.74 – $1.86
- Volume
- 13,384
- Average volume (20 days)
- 19,941
- Beta (5 years)
- 0.66
- 52-week range
- $1.36 – $2.95
- RSI (14 days)
- 49.5
- Volatility (1 year)
- 72.3%
- Relative volume
- 0.58×
- WACC
- 8.2%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | TXMD | S&P 500 | Difference | TXMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -10.2% | -2.4% | −7.8 pts | ||
| 3 months | -10.6% | -1.2% | −9.5 pts | ||
| Year to date | +13.5% | +12.3% | +1.2 pts | ||
| 1 year | +13.1% | +12.4% | +0.7 pts | ||
| 3 years | -7.5% | +78.8% | −86.3 pts | -2.6% | +21.4% |
| 5 years | -94.4% | +75.2% | −169.6 pts | -43.8% | +11.9% |
| 10 years | -99.4% | +311.1% | −410.5 pts | -40.4% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases TherapeuticsMD filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About TherapeuticsMD
Pharmaceutical Preparations
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company that generates revenue by out-licensing pharmaceutical products to commercial healthcare organizations. Its intellectual property portfolio centers on women's healthcare therapies, encompassing IMVEXXY for dyspareunia, BIJUVA for menopausal vasomotor symptoms, ANNOVERA for long-acting contraception, and prescription prenatal vitamin lines. The company does not conduct research, manufacturing, or direct commercial distribution. Instead, its direct customers and commercial partners are third-party pharmaceutical companies that manage the development, manufacturing, regulatory compliance, and marketing of these licensed treatments.
Company profile, executives and historyTherapeuticsMD stock: common questions
What is TherapeuticsMD's stock price?
TXMD closed at $1.85 on Nov 11, 2026, up 6.32% on the day. Over the past 52 weeks it traded between $1.36 and $2.95.
What is TherapeuticsMD's market cap?
TherapeuticsMD was worth $21.41M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is TXMD's P/E ratio?
TherapeuticsMD lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does TherapeuticsMD make?
TherapeuticsMD reported revenue of $3.27M for the twelve months to Jun 30, 2026, up 27.8% from a year earlier.
Does TherapeuticsMD pay a dividend?
No. TherapeuticsMD has not paid a cash dividend over the last twelve months.
When does TherapeuticsMD report earnings next?
TherapeuticsMD is expected to report Q3 FY2026 results on Nov 12, 2026, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has TXMD stock performed over the past year?
Including dividends, TXMD returned +13.1% over the past year, against +12.4% for the S&P 500.
How many TXMD shares are sold short?
0M shares were sold short at the latest FINRA report, 0.27% of the float, or 1.5 days of average trading volume.
Who are TherapeuticsMD's competitors?
Companies most similar to TherapeuticsMD by business, industry and size include DARE, PMHS, BIOE, RANI, PTPI.
See a number that looks wrong?